iStock-1214516643_sm.jpg
 
 

our purpose

Empowering people with OCD to live beyond the limits of their disease.

 
 
iStock-1154560560-2.jpg

Obsessive Compulsive Disorder (OCD) is an insidious disease.

It creates a fog of uncertainty that disrupts daily routines. It causes anxiety, depression, loneliness, and despair. It destroys the quality of life, and can undermine the will to live.

African-American-mother-consoling-her-sad-girl-at-home.-1077179266_6720x4480_Square.jpg

It affects up to 3 million adults and 500,000 children in the U.S. — yet many cases go unreported + untreated.

Feelings of shame and stigma keep it hidden from loved ones. It is often misdiagnosed, and presents with comorbidities, like anxiety or depression. It takes 11 years, on average, to receive treatment after meeting initial diagnostic criteria.

iStock-1211879060.jpeg

And while there are effective treatments for some, they don’t work for everyone.

Every patient is different—there 
is no one-size-fits-all solution. ~1/3 of patients are treatment-resistant—their symptoms withstand existing therapies. Primary treatments from 30 years ago remain largely unchanged today.

 
 

our vision

We’re taking a radical new approach to funding OCD research and breakthroughs.

 
 
BrainNetworkAbstract.jpg.001.jpeg

Strategy

Our strategy is designed with the intention to deliver a “functional” cure for OCD in our lifetime. To do that, we’re pursuing multiple projects across multiple disciplines simultaneously: Genetics, Neuroscience, and Therapeutics. We’re also building key infrastructure to facilitate real-time sharing of data and insights, and funding “moon shot” projects beyond our core focus.

Scientists

Our current team of core investigators includes leading scientists and physicians in the areas of genetics, neuroscience, psychiatry, and therapeutics. They have achieved breakthroughs in the fields of depression, autism, neuromodulation, and laboratory methods. They are leaders in their respective fields and their life’s work is essential to our strategy.

Seed Grants

Our current seed grants encompass a range of projects that include pilot studies of the potential therapeutic efficacy of novel interventions (e.g. tDCS) as well as preclinical studies of the functions of specific synaptic proteins implicated in OCD.

 

 

The Foundation for OCD Research

 Beyond 
the limits of OCD